Age and baseline anxiety in Lysenko’s peptide stress models
A. V. Lysenko · 2006 · Doctoral dissertation, 244 pp., introduction and conclusions
Indexed 2026-11-09.
Related evidence maps: Military & occupational research ↗
Reported findings and study design
The author reported that the direction of peptide-associated changes depended on age and baseline anxiety. Some shifts were unfavorable.
Hypokinesia, hypoxia and exertion models, with behavioral, immune and oxidative endpoints. Twenty-four-hour hypokinesia was one stress protocol.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| High-anxiety young rats | Vilon and GVS-111 were highlighted in the author’s conclusions | Original group-level numerical estimates and doses still need retrieval. |
| Stress-response direction | Favorable and unfavorable responses described | The author discusses this for GVS-111 and an experimental preparation called NKT. NKT identity remains unresolved. |
A mechanistic program on stress response. The dissertation-level conclusion does not isolate all preparation-specific effects.
Source for the extracted data ↗ · Checked 2026-11-09
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Potential overlap with narrower author-network dissertations, including Morgul and Rudenko. Outcomes cannot be pooled or assigned to humans.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Author’s abstract transcription. Full dissertation and underlying records unavailable.
Review depth: Reported methods, results and evidence limitations
Source access and review scope
Author’s abstract transcription. Full dissertation and underlying records unavailable.
Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.
Source type: Doctoral dissertation, 244 pp., introduction and conclusions
Citation and original source
Original source: A. V. Lysenko. Age and baseline anxiety in Lysenko’s peptide stress models Doctoral dissertation, 244 pp., introduction and conclusions 2006.
Molekul research summary: https://molekul.io/research/lysenko-stress-adaptation-2006. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Epithalamin
A pineal-gland tissue extract containing a mixture of peptides. Human aging and melatonin studies of this preparation must be distinguished from research on synthetic Epitalon (AEDG).
Epitalon
Synthetic AEDG has direct human hormone and retinal findings. Long-term Epithalamin mortality studies concern the extract and are kept separate.
Vilon
Defined Lys–Glu (KE) dipeptide with historical adjunct-treatment reports in type 1 diabetes and separate laboratory research. Immune and coagulation-marker findings do not establish autoimmune disease modification.
Cortagen
Listed in the 2013 short-peptide review under the authors’ proposed brain target. This historical label is not an established indication. Underlying studies need individual review.
DSIP
A peptide first characterized in Swiss sleep research and later studied in Soviet/Russian analogue and stress-adaptation programs. Ordinary DSIP, modified analogues and piracetam combinations have distinct evidence.
Noopept
A defined synthetic dipeptide derivative connecting nootropic research with experimental environmental adaptation. Human chamber studies, clinical EEG reports and preclinical mechanisms address different questions; none establishes safe hazardous-work use.